• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Henry Schein Participates in the FDI World Dental Congress 2024 in Istanbul, Turkey

    9/12/24 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care
    Get the next $HSIC alert in real time by email

    Dental Leaders Collaborate to Advance EHR Interoperability, Mentor Young Dentists, Empower Women Dentists, and Promote the Economic Benefits of Expanded Oral Health Coverage

    Henry Schein, Inc. (NASDAQ:HSIC) will participate in and present at the FDI World Dental Congress 2024 taking place in Istanbul, Turkey, from September 12-15, 2024. The FDI World Dental Federation (FDI) represents more than 1 million dentists from 134 different countries and comprises approximately 200 national member dental associations and specialist groups.

    At this year's Congress, FDI's Electronic Health Record (EHR) Task Team will unveil its inaugural Consensus Statement. This statement, the culmination of a 2022 Henry Schein-supported project, outlines the essential EHR data fields that should be shared between medical and dental professionals to facilitate seamless interprofessional collaboration and comprehensive patient care. Additionally, there will be presentations and gatherings arising from initiatives supported by Henry Schein, including a young dental professionals forum, initiatives to support women in dentistry, and a panel discussion highlighting the economic benefits of including oral health coverage within health care policies and plans.

    "The FDI is the global convener for organized dentistry, and its annual Congress brings together global dental professionals, leading academics, and industry stakeholders to showcase the latest advancements and best practices in dentistry and discuss opportunities for implementation partnerships," said David Kochman, Chief Corporate Affairs Officer at Henry Schein. "This year's Congress will showcase key aspects of Henry Schein's commitment to innovation, excellence in the oral health industry, and deep collaboration with the profession."

    Advancing the Integration of Electronic Health Records in Dentistry

    On September 13, Dr. Ryan Hungate, Chief Clinical Officer at Henry Schein One, will present on "Interprofessional Collaboration: Reforming Health Systems Through Electronic Health Records," discussing the importance of standardized data fields across medical and dental EHRs to improve interoperability and patient care.

    Dr. Hungate's presentation is part of a larger, multi-year collaboration between Henry Schein and FDI to establish standardized benchmark best practices of interoperability for specific information field sharing across medical and dental EHRs. The EHR Task Team – led by Dr. Mark Wolff (USA) and Dr. Jina Linton (Korea) – will share FDI's first Consensus Statement on EHR interoperability, including a core set of oral health indicators and baseline EHR interoperability standards that should be shared across medical and dental EHRs to advance interprofessional collaboration. This initiative aligns with the Company's commitment to advancing interprofessional collaboration and transforming health care delivery through technology and innovation.

    Supporting the Next Generation of Dentists

    As a founding supporter of the Young Dentists Forum, Henry Schein will once again participate in the second edition of this global program to convene, inspire, and empower young dental professionals. The program offers practitioners, researchers, and students a unique opportunity to connect with a global community, learn from industry leaders, present their work, and gain valuable insights into the latest advancements in dentistry.

    The 2024 Young Dentists Forum will take place September 13-14, 2024, and will include, among other notable events, comments from Nicola Loynes, Vice President, Special Markets EMEA at Henry Schein, on the afternoon of September 13, and a keynote presentation by Dr. Miguel Stanley (Portugal), who will lead a session entitled, "Leading in Dentistry: Mindset for Success."

    Empowering Women in Dentistry

    On September 13, 2024, the FDI Section of Women Dentists Worldwide will offer a full-day learning and networking session to educate and connect female dental leaders across the globe. Among Henry Schein's panel participants discussing the topic of how we can improve women dentists' competitiveness in the dental arena will be Ms. Loynes and Dr. Sara Hurley, Senior Consultant, Global Professional Relations at Henry Schein.

    Developing the Economic Case for Investing in Oral Health

    Finally, Henry Schein is excited to convene a panel discussion highlighting the economic benefits of investing in oral health on September 14, 2024, as part of the World Economic Forum's (WEF) Oral Health Affinity Group, of which Henry Schein is a founding partner. This global initiative seeks to unite industry leaders and stakeholders to address the pressing challenges facing oral health worldwide and advance the economic rationale for national governments and all payors to provide comprehensive oral health coverage as part of the broader case for universal health coverage. A recent WEF paper sets forth the longitudinal data evidencing the strong correlation between oral health and overall health outcomes, along with the attendant benefits to population health, employee productivity, and family stability. By showcasing the Oral Health Affinity Group's work at the FDI World Dental Congress, Henry Schein and its partners hope to further awareness and dialogue with the goal of increasing oral health coverage as part of overall health care policies and economic stimulus strategies.

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and @HenrySchein on X.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240910327592/en/

    Get the next $HSIC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HSIC

    DatePrice TargetRatingAnalyst
    4/16/2026Neutral
    BTIG Research
    4/15/2026$100.00Buy
    Citigroup
    2/23/2026$100.00Neutral → Outperform
    Robert W. Baird
    12/9/2025$86.00Overweight
    Barclays
    8/26/2025$83.00In-line → Outperform
    Evercore ISI
    7/25/2025$75.00Buy → Hold
    Stifel
    7/14/2025$72.00Outperform → Neutral
    Robert W. Baird
    2/14/2025$80.00Equal Weight
    Wells Fargo
    More analyst ratings

    $HSIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Popeck Thomas C

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/20/26 4:07:39 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SVP & Chief Financial Officer South Ronald N. covered exercise/tax liability with 5,216 shares, decreasing direct ownership by 6% to 88,930 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/17/26 4:17:50 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SVP, Chief Human Res. Officer Sheehy Christine Zayac covered exercise/tax liability with 463 shares, decreasing direct ownership by 2% to 18,454 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/17/26 4:15:54 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Henry Schein

    BTIG Research initiated coverage of Henry Schein with a rating of Neutral

    4/16/26 8:03:48 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Citigroup initiated coverage on Henry Schein with a new price target

    Citigroup initiated coverage of Henry Schein with a rating of Buy and set a new price target of $100.00

    4/15/26 8:08:55 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Henry Schein from Neutral to Outperform and set a new price target of $100.00

    2/23/26 8:29:17 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    SEC Filings

    View All

    SEC Form DEFA14A filed by Henry Schein Inc.

    DEFA14A - HENRY SCHEIN INC (0001000228) (Filer)

    4/8/26 7:02:09 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Henry Schein Inc.

    DEF 14A - HENRY SCHEIN INC (0001000228) (Filer)

    4/8/26 7:00:23 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.

    SCHEDULE 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    3/27/26 9:30:37 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel William K bought $670,800 worth of shares (10,000 units at $67.08) (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    8/11/25 4:26:33 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders

    Stanley M. Bergman to retire from the Board and be named Chairman Emeritus Henry Schein's Board to be reduced to 10 directors following the 2026 Annual Meeting of Stockholders Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of Directors following its 2026 Annual Meeting of Stockholders on May 21, 2026. Stanley M. Bergman is to retire from the Board after 44 years as a director of Henry Schein. In recognition of Mr. Bergman's leadership and the significant contributions he has made to the Company, the Board will designate Mr. Bergman Cha

    4/8/26 7:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein One Unveils the Next Era of Dentrix Ascend for DSOs and Growth-Focused Practices

    New Packages Accelerate Revenue Through an Integrated, Agentic Platform Henry Schein One, the market leader in dental practice management systems, today unveiled the next era of Dentrix Ascend—introducing three new packages built on a fully integrated, agentic platform architecture designed to help practices and Dental Service Organizations (DSOs) increase revenue and accelerate growth. The new offering strengthens Dentrix Ascend's position as the platform of choice for modern dental organizations while advancing Henry Schein One's strategy to unify practice management, clinical workflows, imaging, and revenue cycle management within a single intelligent platform. Momentum behind Dent

    3/10/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein to Participate in Upcoming Investor Conferences in March

    Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conferences in March: Leerink's Global Healthcare Conference at the W South Beach hotel, Miami, on March 9, at 10:00 a.m. EST. Barclays 28th Annual Global Healthcare Conference at the Loews Miami Beach hotel, Miami, on March 10, at 10:30 a.m. EST. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a so

    3/3/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Leadership Updates

    Live Leadership Updates

    View All

    Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer

    Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S. Henry Schein, Inc. (NASDAQ:HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115495488/en/CLIA Waived CitoCBC System Des

    1/15/26 10:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Names Frederick M. Lowery as Chief Executive Officer

    Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire

    1/12/26 7:00:00 AM ET
    $HSIC
    $TMO
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

    Mr. Bergman to Continue to Serve as Chairman of the Board Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of the year after 45 years at the Company, including more than 35 years as CEO. Mr. Bergman will continue to lead Henry Schein in his current role until his retirement and will remain as Chairman thereafter. The Board is commencing a formal search process in conjunction with a nationally recognized executive search firm and will consider internal and external candidates. "With the progress made advan

    7/15/25 7:05:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    11/13/24 3:30:01 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Henry Schein Inc.

    SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

    11/12/24 9:32:27 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Henry Schein Inc. (Amendment)

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    2/14/24 11:18:57 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Financials

    Live finance-specific insights

    View All

    Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance

    Q4 2025 GAAP diluted EPS of $0.85, compared to $0.74 GAAP diluted EPS in Q4 2024 Q4 2025 non-GAAP diluted EPS of $1.34, compared to $1.19 non-GAAP diluted EPS in Q4 2024 2026 non-GAAP diluted EPS expected to be in the range of $5.23 to $5.37, with total sales growth expected to be 3-5% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter ended December 27, 2025. "Our fourth-quarter sales reflect continuing momentum resulting in the highest sales growth in 15 quarters. We are pleased with the sales results across all our businesses, particul

    2/24/26 6:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry S

    1/22/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

    Q3 2025 GAAP diluted EPS of $0.84, compared to $0.78 GAAP diluted EPS in Q3 2024, and Q3 2025 non-GAAP diluted EPS of $1.38, compared to $1.22 non-GAAP diluted EPS in Q3 2024 Raises 2025 guidance for non-GAAP diluted EPS to $4.88 to $4.96 and sales growth to 3-4% to reflect third quarter results Announces value creation initiatives expected to deliver over $200 million of operating income improvement over the next few years Agreement reached to provide KKR the right to increase its HSIC stock ownership up to 19.9% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results

    11/4/25 6:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care